Cogent Biosciences (COGT) total debt

Total debt · fiscal 2025
$238.80M

Cogent Biosciences (COGT) carried total debt of $238.80M at the end of fiscal 2025 (December 31, 2025). That is 1267.1% higher than the $17.47M of fiscal 2024. Figures as of 18 Nov 2026, 05:19 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$238.80M
Change on fiscal 2024
+1267.1%
Highest on record
$238.80Mfiscal 2025
Lowest on record
$17.47Mfiscal 2024
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Cogent Biosciences total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $238.80M in fiscal 2025 and the lowest $17.47M in fiscal 2024.

Total debt was 0.4× shareholders' equity at the end of fiscal 2025.

History · 4 fiscal years

Total debt by fiscal year

Cogent Biosciences total debt, year by year

Cogent Biosciences (COGT) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$238.80M 1,267.1% up0.4×
2024$17.47M 7.4% down0.1×
2023$18.85M 4.1% down0.1×
2022$19.65M—0.1×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Cogent Biosciences and comparable companies
CompanyTotal debtFiscal year
Grifols GRFS€9.57B2025
Cogent Biosciences COGT$238.80M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on COGT

Cogent Biosciences, figure by figure

Cogent Biosciences (COGT) overview: price, valuation and scorecardAll health care companies by market value

Cogent Biosciences total debt: questions and answers

How much debt does Cogent Biosciences have?

Cogent Biosciences (COGT) carried total debt of $238.80M at the end of fiscal 2025 (December 31, 2025). That is 1267.1% higher than the $17.47M of fiscal 2024.

What are the highest and lowest total debt figures on record for Cogent Biosciences?

Across the 4 fiscal years on record (2022–2025), the highest was $238.80M in fiscal 2025 and the lowest $17.47M in fiscal 2024.

How does Cogent Biosciences's debt compare with its equity?

Total debt was 0.4× shareholders' equity at the end of fiscal 2025.

How is Cogent Biosciences's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Cogent Biosciences (COGT) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/COGT/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.